CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −5,245 | 5,245 | ||
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Unit | +21,400 | 21,400 | ||
| 2026-01-06 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +29,000 | 29,000 | ||
| 2026-01-06 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise | +5,545 | 18,796 | ||
| 2026-01-06 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit | −5,545 | 5,545 | ||
| 2026-01-06 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Grant or award · Restricted Stock Unit | +17,100 | 17,100 | ||
| 2026-01-06 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Grant or award · Stock Option (right to buy) | +23,200 | 23,200 | ||
| 2026-01-06 | RENTON HOLLINGS Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-01-06 | RENTON HOLLINGS Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-01-06 | FENTON DENNIS M Director | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | ||
| 2026-01-06 | FENTON DENNIS M Director | Grant or award · Restricted Stock Unit | +4,000 | 4,000 | ||
| 2026-01-05 | Lizzul Paul F. Chief Medical Officer | Sale | −4,219 | $43.26 | $183K | 33,303 |
| 2026-01-05 | Faga Daniel President, CEO | Sale | −15,309 | $43.26 | $662K | 458,139 |
| 2026-01-05 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −3,363 | $43.26 | $145K | 14,330 |
| 2026-01-05 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | −2,983 | $43.26 | $129K | 13,251 |
| 2026-01-03 | Lizzul Paul F. Chief Medical Officer | Option exercise | +10,555 | 37,522 | ||
| 2026-01-03 | Lizzul Paul F. Chief Medical Officer | Option exercise · Restricted Stock Unit | −10,555 | 21,110 | ||
| 2026-01-03 | Faga Daniel President, CEO | Option exercise | +34,677 | 473,448 | ||
| 2026-01-03 | Faga Daniel President, CEO | Option exercise · Restricted Stock Unit | −34,677 | 69,355 | ||
| 2026-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise | +8,292 | 17,693 |
Page 8 of 17 · 339 trades